Genetic risk factors for liver disease (NAFLD) were associated with lipid and glucose metabolism, including peroxisome proliferator-activated receptor-alpha (PPARA), PPARG, LIPIN1, and insulin receptor substrate 1 (IRS1) [122]. This evidence concerns the gene IRS1 and metabolic dysfunction-associated steatotic liver disease.